Sciwind has two Western partners for its obesity drug, but is open to more

GLP-1 Prescriptions Surge Sevenfold Among Women With PCOS: What to Know About Off-Label Use

GLP-1 drug prescriptions (like Ozempic, Wegovy, Zepbound, Mounjaro) among women with PCOS have surged over sevenfold since 2021, despite the

Novo Nordisk launches first GLP-1 weight loss pill Wegovy in US at lower price than injections

Novo Nordisk has launched the first pill version of its blockbuster GLP-1 weight loss drug Wegovy in the US at a significantly lower price t

Conflicts of interest threaten integrity of GLP-1 therapy guidance amid rapid adoption

This article discusses the rapid uptake and commercial success of GLP-1 receptor agonists for obesity management, highlighting their clinica

Conflicts of interest threaten integrity of GLP-1 therapy guidance, experts warn

This article discusses the risks of conflicts of interest in clinical guidance for GLP-1 receptor agonists (like Ozempic, Wegovy) used for o

GLP-1 Therapy Reduces Migraine Frequency by More Than Half in Obesity Patients

A study from the University of Naples found that liraglutide, a GLP-1 receptor agonist typically used for diabetes and obesity, significantl

GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation